This article is available in: PDF HTML EPUB XML

Pharmacokinetics-based adherence measures for antiretroviral therapy in HIV-infected Kenyan children

Wanzhu Tu, Winstone M. Nyandiko, Hai Liu, James E. Slaven, Michael L. Scanlon, Samuel O. Ayaya, Rachel C. Vreeman

Abstract


Background: Traditional medication adherence measures do not account for the pharmacokinetic (PK) properties of the drugs, potentially misrepresenting true therapeutic exposure.

Methods: In a population of HIV-infected Kenyan children on antiretroviral therapy including nevirapine (NVP), we used a one-compartment model with previously established PK parameters and Medication Event Monitoring Systems (MEMS®)-recorded dosing times to estimate the mean plasma concentration of NVP (Cp) in individual patients during 1 month of follow-up. Intended NVP concentration (Cp’) was calculated under a perfectly followed dosing regimen and frequency. The ratio between the two (R = Cp/Cp’) characterized the patient’s NVP exposure as compared to intended level. Smaller R values indicated poorer adherence. We validated R by evaluating its association with MEMS®-defined adherence, CD4%, and spot-check NVP plasma concentrations assessed at 1 month.

Results: In data from 152 children (82 female), children were mean age 7.7 years (range 1.5–14.9) and on NVP an average of 2.2 years. Mean MEMS® adherence was 79%. The mean value of R was 1.11 (SD 0.37). R was positively associated with MEMS® adherence (p < 0.0001), and lower-than-median R values were significantly associated with lower NVP drug concentrations (p = 0.0018) and lower CD4% (p = 0.0178), confirming a smaller R value showed poorer adherence.

Conclusion: The proposed adherence measures, R, captured patient drug-taking behaviours and PK properties.

Keywords pharmacokinetics; adherence; electronic dose monitoring; Nevirapine; measurement validation; pediatrics

To access the supplementary material to this article please see Supplementary Files under Article Tools online.

(Published: 15 June 2017)

Tu W et al. Journal of the International AIDS Society 2017, 20:21157

http://www.jiasociety.org/index.php/jias/article/view/21157 | http://dx.doi.org/10.7448/IAS.20.1.21157




Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Journal of the International AIDS Society | eISSN 1758-2652 | Editors-in-Chief: Susan Kippax and Kenneth Mayer

*2016 Journal Citation Reports® Science Edition - a Clarivate Analytics product.

Disclaimer: The Journal of the International AIDS Society is an official journal of and is published by the International AIDS Society. The costs of the Journal of the International AIDS Society are secured by the International AIDS Society. This support does not in any way affect the editorial independency of the Journal of the International AIDS Society. Material published in the journal is entirely independent of the opinion of external sponsors and the society.